filmov
tv
Will HbA1c become irrelevant in diabetes management? - Dr. Jothydev Kesavadev, Endocrinology
Показать описание
In addition to the free learning material available on this link, we love to hear your feedback and topic requests. Please follow this link for both:
One of the goals of therapy in diabetes is to ensure that patients achieve their glycemic targets and maintain it. For this, we have used many monitoring methods, one of which, is the well-known HbA1c (glycated hemoglobin) test.
In this 10Min CME episode, Dr. Jothydev Kesavadev, a diabetologist who is renowned all over India for his contribution to the understanding and awareness of the disease, will explore the reasons that HbA1c is limited in its use in diabetes care. He will also shed some light on the new metric which is taking centre stage in diabetes care - Time-In-Range.
Chapters:
Will HbA1c become irrelevant in the management of diabetes?
0:00 Average HbA1c in India
0:51 Introduction
1:11 Why we can't rely on HbA1c
2:50 Time-in-range & HbA1c
5:00 Normal TIR in DM
6:14 Normal TIR in DM with complications
7:05 Normal TIR in pregnancy
8:02 Why should we use TIR?
8:18 AGP Report
8:33 Continuous glucose monitoring
9:15 Key takeaways
10:14 Thank you!
Dr. Jothydev Kesavadev is chairman of the Jothydev's Diabetes Research Center and he is based out of Trivandrum. He is an avid speaker in diabetes and has contributed much to our understanding of diabetes in the Indian scenario.
Please leave your comments, feedback, doubts, suggestions and/or ideas in the comments section below.
Please subscribe to 10Min CME and learn on-the-go.
One of the goals of therapy in diabetes is to ensure that patients achieve their glycemic targets and maintain it. For this, we have used many monitoring methods, one of which, is the well-known HbA1c (glycated hemoglobin) test.
In this 10Min CME episode, Dr. Jothydev Kesavadev, a diabetologist who is renowned all over India for his contribution to the understanding and awareness of the disease, will explore the reasons that HbA1c is limited in its use in diabetes care. He will also shed some light on the new metric which is taking centre stage in diabetes care - Time-In-Range.
Chapters:
Will HbA1c become irrelevant in the management of diabetes?
0:00 Average HbA1c in India
0:51 Introduction
1:11 Why we can't rely on HbA1c
2:50 Time-in-range & HbA1c
5:00 Normal TIR in DM
6:14 Normal TIR in DM with complications
7:05 Normal TIR in pregnancy
8:02 Why should we use TIR?
8:18 AGP Report
8:33 Continuous glucose monitoring
9:15 Key takeaways
10:14 Thank you!
Dr. Jothydev Kesavadev is chairman of the Jothydev's Diabetes Research Center and he is based out of Trivandrum. He is an avid speaker in diabetes and has contributed much to our understanding of diabetes in the Indian scenario.
Please leave your comments, feedback, doubts, suggestions and/or ideas in the comments section below.
Please subscribe to 10Min CME and learn on-the-go.
Комментарии